OBGYN Associates of North Jersey Partners with Axia Women’s Health

OBGYN Associates of North Jersey, a premier women’s healthcare practice, has partnered with Axia Women’s Health. Axia is a regional women’s health network with offices in New Jersey, Pennsylvania, Ohio, and Indiana. Founded by Hugo Kitzis, M.D., in 1973, OBGYN Associates provides state-of-the-art women’s healthcare to Northern New Jersey. The practice has seven physicians and three nurse practitioners who offer a full range of obstetrics and gynecology services through a woman’s life cycle – from initial exam and routine care, to childbirth, to menopause and beyond.

Vios Fertility Institute Acquires Center for Reproductive Health

Known to be one of the “fastest growing and innovative fertility clinics in the U.S.,” Vios Fertility Institute announces the acquisition of Center for Reproductive Health, a widely-respected fertility practice founded by Dr. Scott Springer with locations in Crest Hill, IL and Geneva, IL. Vios is led by CEO and Chief Medical Officer Dr. Angeline Beltsos, who is board certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility (REI), practicing medicine since 1991. Dr. Beltsos, along with Vios physicians including Dr. Roohi Jeelani and Dr. Erica Louden, will join Dr. Springer in serving patients at the Crest Hill and Geneva locations.

‘Femtech’ May Have Its Moment as Investors Target Specialized Digital Health

The pandemic-fueled popularity of online tools for primary and chronic care have emboldened investors to seek more specialized opportunities in digital health. Women’s health may be their next target. With patients pushed online by COVID-19, companies like Teladoc Health Inc. — whose share price more than doubled in 2020 — got a warm reception on Wall Street. That led to greater interest in digital tools aimed at treating a chronic care population with conditions like diabetes and heart disease. The enthusiasm has not quite caught up with digital women’s health, often dubbed femtech. That may change.

Ro Acquires Modern Fertility to Accelerate Its Leadership in Women’s Health

Ro, the healthcare technology company, today announced the acquisition of Modern Fertility, a high-growth reproductive health company focused on addressing gaps in women’s healthcare through fertility testing, research, education, and community. Since 2017, Modern Fertility has empowered people with ovaries nationwide to play a more active role in their health and build the lives they want on their own terms. The acquisition represents a dramatic expansion of Ro’s women’s health offering, adding Modern Fertility—one of the fastest growing women’s health businesses in the country—to Ro’s vertically-integrated primary care platform.

Partners Group to Acquire Axia Women’s Health, A Leading US Provider of Women’s Healthcare Services

Partners Group, a leading global private markets firm, has, on behalf of its clients, agreed to acquire Axia Women’s Health (“Axia” or the “Company”), a leading women’s healthcare provider in the US, from Audax Private Equity. Partners Group will become the majority equity holder, while Axia’s management team and physician partners will retain a substantial minority equity stake. Axia has partnered with more than 80 care centers comprising 150 locations and supporting 475,000 patients annually, which offer a wide range of care, including obstetrics, gynecology, laboratory, mammography, urogynecology, fertility, and other sub-specialties.

U.S. Birth Rate Falls to Lowest Point in More Than a Century

The U.S. birth rate fell 4 percent last year, the largest single-year decrease in nearly 50 years, according to a government report released Wednesday. The rate dropped for moms of every major race and ethnicity, and in nearly age group, falling to the lowest point since federal health officials started tracking it more than a century ago. Births have been declining in younger women for years, as many postponed motherhood and had smaller families. Birth rates for women in their late 30s and in their 40s have been inching up. But not last year.

Perinatal Safety Company PeriGen, Inc., Acquired by Halma plc

PeriGen, Inc., the market leader in applying artificial intelligence (AI) to improve safety in childbirth, today announced it has been acquired by Halma plc. Based in the UK, Halma is a FTSE 100 global group of life-saving technology companies that provide innovative solutions to many of the key problems facing the world today – such as avoidable adverse events in childbirth. PeriGen’s unique technology helps protect mothers and their unborn babies by using AI tools to continuously monitor laboring patients to identify and highlight troubling trends over the course of labor.

Pandemic Highlights Need for Urgent Care Clinics for Women

For years, many women with common but urgent conditions like painful urinary tract infections or excessive bleeding in the aftermath of a miscarriage have faced a grim choice between waiting weeks for an appointment with their regular OB-GYN or braving hours in an ER waiting room. Urgent care OB-GYN clinics have begun popping up around the country in recent years, and the covid pandemic has increased demand. While no data is available on the number of urgent care clinics for women, they are part of a surge of interest in urgent care clinics in general and other alternative models like retail clinics and so-called digital-first health care startups.

STDs Again Hit All-Time High in U.S.

For the sixth consecutive year, reported cases of the sexually transmitted diseases chlamydia, gonorrhea, and syphilis in the U.S. hit an all-time high in 2019, the Centers for Disease Control and Prevention said in a new report this week. “Less than 20 years ago, gonorrhea rates in the U.S. were at historic lows, syphilis was close to elimination, and advances in chlamydia diagnostics made it easier to detect infections. That progress has been lost, due in part to challenges to our public health system,” Raul Romaguera, acting director of the CDC’s Division of STD Prevention, wrote in an announcement accompanying the report.

Is ‘Femtech’ the Next Big Thing in Health Care?

In 2019, the “femtech” industry — software and technology companies addressing women’s biological needs — generated $820.6 million in global revenue and received $592 million in venture capital investment, according to PitchBook, a financial data and research company. That same year, the ride-sharing app Uber alone raised $8.1 billion in an initial public offering. The difference in scale is staggering, especially when women spend an estimated $500 billion a year on medical expenses, according to PitchBook. Tapping into that spending power, a multitude of apps and tech companies have sprung up in the last decade to address women’s needs.